Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to evaluate the effect of tobramycin inhalation solution (TIS) once daily compared tot placebo in patients with non-CF bronchiectasis. The primary endpoint is a reduction of exacerbations of the disease during the treatment period. Next to this parameter the investigators expect to show a significant beneficial effect on lung function parameters, QoL, bacterial load of pathogens in sputum and tobramycin resistance.
Epistemonikos ID: 406d7ec1965ca99038eef6716c2d46050454d74b
First added on: May 12, 2024